Considerations for the Integration of Randomized Controlled Trials and Real-World Data

2026-04-11

AI Summary

This study addresses the limitations of individualized clinical decision-making, which is often constrained by the high internal validity but limited external applicability of randomized controlled trials (RCTs) and the strong representativeness yet susceptibility to confounding bias in real-world data (RWD). To overcome these challenges, the authors propose a multi-source data integration paradigm grounded in an explicit causal inference framework. This approach systematically combines RCT and RWD by rigorously defining estimands, ensuring comparability across data sources, and conducting sensitivity analyses. The resulting methodology enhances the reliability and evidentiary strength of treatment effect estimates while providing a practical, regulatory-compliant pathway for generating individualized treatment recommendations.

Technology Category

• Reasoning under Uncertainty: Causality
• Machine Learning: Causal Learning
• Knowledge Representation and Reasoning: Preferences

Application Category

• User Modeling, Personalization and Recommendation: Fairness-aware retrieval and ranking
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• Responsible Web: Consent frameworks and practices on the web

Abstract

As clinical decision-making increasingly moves toward individualized and context-specific treatment recommendations, reliance on any single evidence source, randomized or observational, may be insufficient. Principled integration of randomized controlled trials and real-world data, grounded in explicit causal frameworks, offers a path toward evidence that is both internally credible and externally relevant. In this article, we describe distinct objectives for the integration of randomized controlled trials and real-world data and discuss how these objectives shape key design and analytic considerations, illustrating the resulting choices through example estimands. We highlight practical issues that commonly arise in applied settings, including data relevance and curation, cross-source comparability, estimand specification, and sensitivity analysis. We aim for this article to help readers evaluate and implement principled approaches to integrating randomized controlled trials and real-world data in ways that can support more reliable treatment recommendations while maintaining regulatory-grade evidentiary standards.

Problem

• randomized controlled trials
• real-world data
• evidence integration
• causal frameworks
• treatment recommendations

Innovation

• randomized controlled trials
• real-world data
• causal inference
• evidence integration
• estimands